Breast J. 2018 Jul 31. doi: 10.1111/tbj.13100. [Epub ahead of print]
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management.
Loi M1, Desideri I1, Olmetto E1, Francolini G1, Greto D1, Bonomo P1, Simontacchi G1, Di Brina L1, Meattini I1, Livi L1.
BRCA1/2 mutations are involved in breast cancer (BC) susceptibility but their influence on outcome is unclear. We reviewed BC patients tested for BRCA to determine biological features and influence on outcome. BRCA-1 was correlated to younger age (P = 0.035), nodal involvement (P = 0.030), higher tumor grade (P = 0.0022) and Ki-67 (P = 0.014), ER/PgR negative status (P = 0.00042 and 0.0091, respectively), and use of adjuvant chemotherapy (P = 0.000038); BRCA was neither predictive for chemotherapy administration nor resulted in impaired outcome or occurrence of secondary BC. BRCA status did not influence outcome despite higher biological aggressiveness and younger age at presentation.
BRCA1/2 mutation; breast cancer; hereditary cancer syndromes; oncogenetics